U50A-mediated mTOR inhibition leads to everolimus resistance in breast cancer

First Author / 第一作者

Jie-Ning Li

Institution / 單位

Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan Department of Medical Laboratory Science and Biotechnology, College of Medicine, NCKU, Tainan, Taiwan

Audio / 音訊檔

Author Group / 作者群

Jie-Ning Li1,2, Jui-Hung Tsai3,4, Yuchieh Chien2,3, Pai-Sheng Chen1,2 ,*, Yao-Lung Kuo3,4,*

Author Group Institution/ 作者群單位

1 Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan 2 Department of Medical Laboratory Science and Biotechnology, College of Medicine, NCKU, Tainan, Taiwan 3 Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Tainan, Taiwan 4 Breast Medical Center, National Cheng Kung University Hospital, Tainan, Taiwan

Category / 主題分類

Basic Research

Keyword / 關鍵字

U50A, everolimus resistance, breast cancer

Back to list